SEC Tracker
Get the app
Person · CIK 2030813

Thomas Trimarchi

President and CFO at BridgeBio Pharma

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$6M
Noticed on Form 144$6M
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
BridgeBio Pharma BBIOCommon StockDirectly336,529Aug 16, 2026 · Filing · EDGAR
BridgeBio Pharma BBIOStock Option (Right to Buy)
exercise $24.87, expires Aug 5, 2034, into Common Stock
Directly3,160Aug 6, 2024 · Filing · EDGAR

Sold and noticed by quarter

Thomas Trimarchi: dollars sold on Form 4 and noticed on Form 144 per quarter, Q1 2025 to Q4 2026$3M$0Q1 2025: $0 noticed on Form 144Q1 2025: $0 sold on Form 4Q2 2025: $0 noticed on Form 144Q2 2025: $0 sold on Form 4Q3 2025: $3M noticed on Form 144Q3 2025: $3M sold on Form 4Q4 2025: $1.1M noticed on Form 144Q4 2025: $1.1M sold on Form 4Q1 2026: $1M noticed on Form 144Q1 2026: $1M sold on Form 4Q2 2026: $888K noticed on Form 144Q2 2026: $888K sold on Form 4Q3 2026: $0 noticed on Form 144Q3 2026: $0 sold on Form 4Q4 2026: $0 noticed on Form 144Q4 2026: $0 sold on Form 4Q1 2025Q3 2025Q1 2026Q3 2026

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table
QuarterSold (Form 4)Noticed (Form 144)
Q2 2026$888K$888K
Q1 2026$1M$1M
Q4 2025$1.1M$1.1M
Q3 2025$3M$3M

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice dateNoticedPlanned saleOutcomeLinks
BridgeBio Pharma BBIO · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 31, 2025 · 4 notices
May 18, 202613,651 · ~$888KMay 18, 2026Sold as noticed Sold 13,651 in 2 sales, May 18 to May 18 · $888K Form 4Filing · EDGAR
Feb 17, 202613,600 · ~$1MFeb 17, 2026Sold as noticed Sold 13,600 in 2 sales, Feb 17 to Feb 17 · $1M Form 4Filing · EDGAR
Nov 17, 202516,934 · ~$1.1MNov 17, 2025Sold as noticed Sold 16,934 in 2 sales, Nov 17 to Nov 17 · $1.1M Form 4Filing · EDGAR
Aug 18, 202517,353 · ~$872KAug 18, 2025Sold as noticed Sold 17,353 in 2 sales, Aug 18 to Aug 18 · $872K Form 4Filing · EDGAR
BridgeBio Pharma BBIO · Morgan Stanley Smith Barney · No 10b5-1 plan stated · 1 notice
Aug 21, 202542,237 · ~$2.1MAug 21, 2025Sold as noticed Sold 42,237 at $49.48 on Aug 21 · $2.1M Form 4Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

BridgeBio Pharma BBIO President and CFO · filings 2024 to 2026 · sold $6M · $6M noticed on Form 144

DateTransactionSharesPriceValueHeld afterSource
Aug 16, 2026Shares withheld for tax or exercise price−22,781$79.86$1.8M336,529 directFiling · EDGAR
May 18, 2026Sale under a 10b5-1 plan−10,456$64.82$678K362,389 directFiling · EDGAR
May 18, 2026Sale under a 10b5-1 plan−3,195$65.95$211K359,194 directFiling · EDGAR
May 16, 2026Shares withheld for tax or exercise price−22,781$66.13$1.5M372,845 directFiling · EDGAR
Mar 18, 2026Grant or award from the company+59,041395,626 directFiling · EDGAR
Feb 17, 2026Sale under a 10b5-1 plan−13,400$74.71$1M336,785 directFiling · EDGAR
Feb 17, 2026Sale under a 10b5-1 plan−200$75.38$15K336,585 directFiling · EDGAR
Feb 16, 2026Shares withheld for tax or exercise price−18,819$75.25$1.4M350,185 directFiling · EDGAR
Dec 12, 2025Shares withheld for tax or exercise price−13,826$75.15$1M369,004 directFiling · EDGAR
Nov 17, 2025Sale under a 10b5-1 plan−9,978$66.19$660K389,786 directFiling · EDGAR
Nov 17, 2025Sale under a 10b5-1 plan−6,956$66.84$465K382,830 directFiling · EDGAR
Nov 16, 2025Shares withheld for tax or exercise price−21,317$66.39$1.4M399,764 directFiling · EDGAR
Aug 21, 2025Open-market or private sale−42,237$49.48$2.1M421,081 directFiling · EDGAR
Aug 18, 2025Sale under a 10b5-1 plan−15,380$50.14$771K465,291 directFiling · EDGAR
Aug 18, 2025Sale under a 10b5-1 plan−1,973$50.94$101K463,318 directFiling · EDGAR
Aug 16, 2025Shares withheld for tax or exercise price−21,317$51.32$1.1M480,671 directFiling · EDGAR
May 16, 2025Shares withheld for tax or exercise price−21,317$33.84$721K501,988 directFiling · EDGAR
Mar 19, 2025Grant or award from the company+109,100523,305 directFiling · EDGAR
Feb 16, 2025Shares withheld for tax or exercise price−13,782$34.90$481K414,205 directFiling · EDGAR
Dec 10, 2024Grant or award from the company+50,000427,987 directFiling · EDGAR
Nov 16, 2024Shares withheld for tax or exercise price−17,936$23.72$425K377,987 directFiling · EDGAR
Aug 16, 2024Shares withheld for tax or exercise price−17,936$24.40$438K395,923 directFiling · EDGAR
Aug 6, 2024Grant or award from the company+19,003413,859 directFiling · EDGAR
Aug 6, 2024Grant or award from the company
Stock Option (Right to Buy)
+3,1603,160 directFiling · EDGAR
All 21 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Aug 18, 2026Form 4BridgeBio Pharma BBIOFiling · EDGAR
May 19, 2026Form 4BridgeBio Pharma BBIOFiling · EDGAR
May 18, 2026Form 144BridgeBio Pharma BBIOFiling · EDGAR
Mar 20, 2026Form 4BridgeBio Pharma BBIOFiling · EDGAR
Feb 18, 2026Form 4BridgeBio Pharma BBIOFiling · EDGAR
Feb 17, 2026Form 144BridgeBio Pharma BBIOFiling · EDGAR
Dec 16, 2025Form 4BridgeBio Pharma BBIOFiling · EDGAR
Nov 18, 2025Form 4BridgeBio Pharma BBIOFiling · EDGAR
Nov 17, 2025Form 144BridgeBio Pharma BBIOFiling · EDGAR
Aug 22, 2025Form 4BridgeBio Pharma BBIOFiling · EDGAR
Aug 21, 2025Form 144BridgeBio Pharma BBIOFiling · EDGAR
Aug 19, 2025Form 4BridgeBio Pharma BBIOFiling · EDGAR
Aug 18, 2025Form 144BridgeBio Pharma BBIOFiling · EDGAR
May 20, 2025Form 4BridgeBio Pharma BBIOFiling · EDGAR
Mar 21, 2025Form 4BridgeBio Pharma BBIOFiling · EDGAR
Feb 19, 2025Form 4BridgeBio Pharma BBIOFiling · EDGAR
Dec 12, 2024Form 4BridgeBio Pharma BBIOFiling · EDGAR
Nov 19, 2024Form 4BridgeBio Pharma BBIOFiling · EDGAR
Aug 20, 2024Form 4BridgeBio Pharma BBIOFiling · EDGAR
Aug 8, 2024Form 4BridgeBio Pharma BBIOFiling · EDGAR
Jul 29, 2024Form 3BridgeBio Pharma BBIOFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.